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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A320intra-articular injection of monoiodoacetate (MIA), and the joint
degeneration was assessed with the OARSI cartilage degeneration score
in histological assessments of the joints of the rats.
Results: The MCP-1 itself enhanced the autocrine of MCP-1 in OA and
normal human cartilage and the Expression of collagen I, V, IX, XI and
Matrix metalloproteinases (MMP) increased after Stimulation of MCP-1.
The MCP-1 also induced the apoptosis of normal and OA chondrocytes.
The CCR-2 antagonist retarded the establishment of a monoiodoacetate
(MIA)-induced animal model of OA in rats.
Conclusions: The results of this study prove that the MCP-1-CCR2
ligand-receptor axis plays an important role in the progress of the OA's
pathology. Inhibition of the MCP-1-CCR2 ligand-receptor axis may
retard the pathological progress of human OA. And, we speculate that
lots of OA patients that etiology is unclear can gain some cues from the
MCP-1-CCR2 ligand-receptor axis, according to our present study.
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BONE GEOMETRY OF THE HIP IS ASSOCIATED WITH OBESITY AND
EARLY STRUCTURAL DAMAGE e A 3.0T MRI STUDY OF
COMMUNITY-BASED ADULTS
A. Teichtahl y, Y. Wang z, S. Smith z, A. Wluka z, M. Zhu z, D. Urquhart z,
G. Giles x, R. O'Sullivan z, F. Cicuttini z. yBaker IDI/Monash Univ.,
Melbourne, Australia; zMonash Univ., Melbourne, Australia; xCancer
Council Victoria, Melbourne, Australia
Purpose: The mechanism by which obesity increases the risk of hip
osteoarthritis (OA) is unclear. One mechanism may be by mediating
abnormalities in bony geometry, which may in turn be associated with
early structural abnormalities, such as cartilage defects and bone mar-
row lesions (BMLs).
Methods: 141 older adults with no diagnosed hip OA had weight and
body mass index (BMI) measured between 1990 and 1994 and again in
2009-10. Acetabular depth and lateral centre edge angle (LCEA), both
measures of acetabular over-coverage, as well as femoral head cartilage
volume, cartilage defects and BMLs were assessed with 3.0T MRI per-
formed in 2009-10.
Results: Current BMI, weight and weight gain were associated with
increased acetabular depth and LCEA (all p  0.01). For every one mil-
limetre increase in acetabular depth, femoral head cartilage volume
reduced by 59mm3 (95% CI 98mm3 to 20mm3, p < 0.01). Greater ace-
tabular depth was associated with an increased risk of cartilage defects
(OR 1.22, 95% CI 1.03e1.44, p ¼ 0.02) and BMLs (OR 1.29, 95% CI
1.01e1.64, p ¼ 0.04) in the central region of the femoral head. LCEAwas
not associated with hip structure.
Conclusions: Obesity is associated with acetabular over-coverage.
Increased acetabular depth, but not the LCEA, is associated with
reduced femoral head cartilage volume and an increased risk of carti-
lage defects and BMLs. Minimising any deepening of the acetabulum,
for example through weight management, might help to reduce the
incidence of hip OA.
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THE BENEFICIAL ROLE OF PAI-1 IN BONE-CARTILAGE INTERACTION
M.F. Pustjens y, S.C. Mastbergen y, W.H. Noort-Van der Laan z,y,
R.J. Van Heerwaarden z, F.P. Lafeber y. yUniv. Med. Ctr. Utrecht, Utrecht,
Netherlands; z St. Maartenskliniek, Woerden, Netherlands
Purpose: In osteoarthritis (OA) subchondral bone changes are seen in
addition to cartilage changes. In treatments targeted at bone, such as
treatment with strontium ranelate (Reginster, 2013), or treatments with
bone involvement such as osteotomy (Jung et al, 2014) or joint dis-
traction (Intema et al, 2012) cartilage repair has been demonstrated.
These studies support the hypothesis that a reset of bone can lead to
cartilage repair. However, the exact biochemical interactions and how
this contributes to repair and degradation processes is less well known.
Plasminogen activator inhibitor (PAI)-1, inhibits plasmin which
accounts for higher levels of MMPs in OA. It is expressed in subchondral
bone and cartilage. The present study evaluates the role of plasminogen
activator inhibitor 1 (PAI-1) in bone-cartilage interaction and its direct
effects on osteoarthritic cartilage.
Methods: Osteoblast culture supernatant from healthy (n¼14) and OA
(n¼16) donors was tested on both healthy and OA cartilage and pro-
teoglycan (PG) synthesis was studied. Expression levels of mediators
were assessed in the osteoblast culture supernatants by Luminexanalysis. Subsequently, OA cartilage (n¼11 donors) was cultured in
absence/presence of PAI-1 and PG synthesis changes were studied.
Results: PG synthesis of OA cartilage was increased (þ34%, p¼0.036)
upon addition of healthy osteoblast supernatant. Importantly, a
decrease was seen when OA osteoblast supernatant was added to
healthy cartilage (-31% PG synthesis, p¼0.001). PAI-1 was expressed at
signiﬁcant higher levels in healthy osteoblasts compared to OA osteo-
blasts (184ng/ml vs 91ng/ml, resp.p¼0.015). Moreover, osteoblast PAI-1
levels were positively correlated with PG synthesis (r¼0.595, p¼0.042)
inﬂuenced by the osteoblasts. Culturing OA cartilage in direct presence
of PAI-1 (2000ng/ml) revealed 33% (p¼0.026) increase of PG synthesis
conﬁrming the beneﬁcial role of PAI-1 in the osteoblast cultures.
Conclusions: Healthy osteoblast derivedmediators lead to PG synthesis
increase in OA cartilage, while it has no effect on healthy cartilage.
Moreover, OA osteoblast derived mediators lead to a decrease in PG
synthesis in healthy cartilage, but not in OA cartilage. Higher PAI-1
levels in these osteoblasts cultures are clearly correlated with higher PG
synthesis in cartilage, which hints at a role for PAI-1 in cartilage repair.
Its direct effects on OA cartilage, increasing PG synthesis, further con-
ﬁrmed the relevance of PAI-1. This supports that targeting bone directly
or involvement of bone might be feasible as treatment for OA.
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INVOLVEMENT OF TGFß1 IN THE INITIAL PHASE OF TMJ AND KNEE
OSTEOARTHRITIS
E.M. Long, R.E. Seegmiller, P. Reynolds. Brigham Young Univ., Provo, UT,
USA
Purpose: The objective of this study was to elucidate OA progression in
an animal model of Stickler syndrome by assessing the expression of an
identiﬁed inﬂammatory marker associated with OA, viz., TGFß1. The
study provides potential mechanistic insight into disease progression
based on the temporal expression of TGFß1 in knee and tempor-
omandibular joints (TMJ).
Methods: The study involved mice carrying the autosomal semi-
dominant disproportionate micromelia (Dmm/þ) mutation in the C-
propeptide coding region of the Col2a1 gene. Speciﬁcally, six wild type
control (þ/þ) and six heterozygous (Dmm/þ) mice were evaluated for
each joint. The mice were euthanized at three, six, and nine months of
age, and their TMJs and knee joints were isolated, ﬁxed, decalciﬁed,
embedded in parafﬁn, and sectioned at 6mm thickness. Three months of
age coincides with the initial detection of histopathology in several
murine models of OA. To determine OA status, selected tissues were
stained with Safranin O to identify proteoglycans and counterstained
with Fast Green. The extent of staining and onset of OA were quantiﬁed
using Modiﬁed Mankin and OARSI scoring systems. Selected tissue
sections of each genotypewere also stained immunohistochemically for
the presence of TGFß1, the inﬂammatory mediator that has been
identiﬁed to play a role in OA progression.
Results: The results revealed Mankin and OARSI scores consistent with
OA-like changes. These changeswere detectable as early as threemonths
in Dmm/þ mice when compared with normal joint biology observed in
control animals. Compared to basal expression in control TMJs and knee
joints, staining for TGFß1 demonstrated augmented expression in Dmm/
þmice as early as threemonths of age, with overexpression persisting in
six-month-old mutant mice, but then disappearing at nine months of
age. The present study demonstrated that TGFß1 was overexpressed in
TMJ and knee articular cartilage of three- and six-month-old Dmm/þ
mice when compared with age-matched controls.
Conclusions: Early TGFb1 expression levels suggested that this
inﬂammatory mediator is involved in the earliest stages of TMJ OA.
Further studies are underway that could shed light on TGFB1 and the
use of other inﬂammatory markers such as HtrA1 and SMADs as pos-
sible targets for therapeutic intervention.
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ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM INTRODUCES
OSTEOARTHRITIS
K. Yamagishi, I. Tsukamoto, M. Akagi. Kinki Univ., Osakasayama City,
Osaka, Japan
Purpose: In 2013, we reported that the local renin-angiotensin system
(RAS) can modulate the hypertrophic differentiation of chondrocytes.
